Vikram Lamba
Nessuna posizione attualmente
Profilo
Mr. Vikram Lamba is President, CEO, Treasurer & Director at Zosano, Inc., Chief Executive Officer & Director at Zosano Pharma Corp.
and Chief Executive Officer & Director at ZP Opco, Inc. He is on the Board of Directors at Zosano, Inc., Zosano Pharma Corp.
and ZP Opco, Inc.
Mr. Lamba was previously employed as Chief Financial Officer by Predictive Biosciences, Inc., a Manager by Bayer AG, Vice President-Corporate Development by Advanced Medical Optics, Inc., a Principal by Burmah Castrol Plc, Head-Sales & Marketing by Castrol Ltd., and Chief Financial Officer & Vice President-Finance by GeneOhm Sciences, Inc.
He received his MBA from Asian Institute of Management.
Precedenti posizioni note di Vikram Lamba
Società | Posizione | Fine |
---|---|---|
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Director of Finance/CFO | 31/10/2023 |
ZOSANO PHARMA CORPORATION | Chief Executive Officer | 06/01/2016 |
J.E.M. CAPITAL INC | Chief Executive Officer | 06/01/2016 |
Predictive Biosciences, Inc.
Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. The Company pioneered the Clinical Intervention Determining Diagnostic (CIDD) and Multi-Analyte Diagnostic Readout (MADR) approaches to cancer management, leveraging its portfolio of patented biomarkers and clinical algorithms. Based on these approaches, the Company is building a unique portfolio of assays that enable physicians to reliably determine the presence or absence of cancer with very high levels of confidence. Predictive Biosciences' first tests are targeted toward the growing bladder cancer and prostate cancer survivor populations and the large number of individuals undergoing clinical workups for these malignancies. Predictive Biosciences' corporate headquarters and innovation center is located in Lexington, Massachusetts. The Company's commercial division, OncoDiagnostic Laboratory (ODL), is located in Cleveland, Ohio. ODL is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians. Founded in 2006, Predictive Biosciences is privately funded by Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. | Director of Finance/CFO | - |
BAYER AG | Corporate Officer/Principal | 01/01/2004 |
Formazione di Vikram Lamba
Asian Institute of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BAYER AG | Health Technology |
Aziende private | 9 |
---|---|
Advanced Medical Optics, Inc.
Advanced Medical Optics, Inc. Medical SpecialtiesHealth Technology Advanced Medical Optics, Inc. manufactures intraocular lens and optical medical devices for eye disorders. Its products includes intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. It develops sovereign system, which is equipped with WhiteStar software that uses ultrasound power to dissolve dense cataracts that can develop in the eye, Amadeus microkeratome, a device used during LASIK procedures and Verisyse phakic IOL for treatment of moderate to severe myopia. It was founded in 1976 Santa Ana, CA. | Health Technology |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
ZP Opco, Inc.
ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Health Technology |
J.E.M. Capital, Inc.
J.E.M. Capital, Inc. Financial ConglomeratesFinance J.E.M. Capital, Inc. is a a shell company, which engages in the identification of a privately held operating company which desires to become a publicly held entity by merging with the firm through a reverse merger or acquisition. The company was founded on September 14, 2011 and is headquartered in Hong Kong. | Finance |
Burmah Castrol Plc
Burmah Castrol Plc Chemicals: SpecialtyProcess Industries Burmah Castrol Plc is an international manufacturer and marketer of specialised lubricants and chemicals, operating in over 60 countries worldwide. The group operates mainly under the Castrol brand name in lubricant | Process Industries |
Castrol Ltd.
Castrol Ltd. Industrial SpecialtiesProcess Industries Castrol, Ltd. produces and offers lubricant solutions for cars and bikes. Its products include engine and gear oils, greases, ancillaries, automatic transmission fluid and brake fluids, and motorcycle care products. The company was founded in 1899 and is headquartered in Swindon, UK. | Process Industries |
Predictive Biosciences, Inc.
Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. The Company pioneered the Clinical Intervention Determining Diagnostic (CIDD) and Multi-Analyte Diagnostic Readout (MADR) approaches to cancer management, leveraging its portfolio of patented biomarkers and clinical algorithms. Based on these approaches, the Company is building a unique portfolio of assays that enable physicians to reliably determine the presence or absence of cancer with very high levels of confidence. Predictive Biosciences' first tests are targeted toward the growing bladder cancer and prostate cancer survivor populations and the large number of individuals undergoing clinical workups for these malignancies. Predictive Biosciences' corporate headquarters and innovation center is located in Lexington, Massachusetts. The Company's commercial division, OncoDiagnostic Laboratory (ODL), is located in Cleveland, Ohio. ODL is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians. Founded in 2006, Predictive Biosciences is privately funded by Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. | Health Services |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Health Technology |
Zosano Pharma Corp.
Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Vikram Lamba